Michael Geffner serves as Executive at Immunovant, Inc., where they oversee executive responsibilities. Since joining the company, Michael Geffner has executed 9 insider transactions totaling $706.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 22, 2025 involved selling 2,595 shares valued at $49.4K.
Michael Geffner currently holds 217,958 shares of Immunovant, Inc. (IMVT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Geffner has been a net seller of IMVT stock. They have purchased $0 and sold $706.6K worth of shares.
Michael Geffner's most recent insider trade was on Oct 22, 2025, when they sold 2,595 shares at $19.03 per share.
Get notified when new Form 4 filings are submitted
| $16.30 |
| Discretionary |
| Jul 23, 2025 | IMVT | $43.3K | Sale | 2,385 | $18.15 | Discretionary |
| Jul 9, 2025 | IMVT | $20.0K | Sale | 1,160 | $17.24 | Discretionary |
| Jul 24, 2024 | IMVT | $95.9K | Sale | 3,456 | $27.76 | Discretionary |
| Apr 24, 2024 | IMVT | $94.2K | Sale | 3,261 | $28.90 | Discretionary |
| Apr 2, 2024 | IMVT | $0 | Award | 54,978 | $N/A | Discretionary |
| Jan 26, 2024 | IMVT | $377.1K | Sale | 9,948 | $37.91 | Discretionary |
| Jan 26, 2024 | IMVT | $5.9K | Sale | 153 | $38.45 | Discretionary |